Cytogenetic findings in a prospective series of patients with DiGeorge anomaly

• Published in: American journal of human genetics 1988-11, Vol.43 (5), p.605-611
• Main Authors: GREENBERG, F, ELDER, F. F. B, HAFFNER, P, NORTHRUP, H, LEDBETTER, D. H
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Child; Child, Preschool; Chromosome Aberrations; Chromosome Banding; Chromosome Deletion; Chromosomes, Human, Pair 22; Complex syndromes; DiGeorge Syndrome - genetics; Female; Humans; Immunologic Deficiency Syndromes - genetics; Infant; Karyotyping; Male; Medical genetics; Medical sciences; Patients; Prospective Studies
• ISSN: 0002-9297; 1537-6605

High-resolution cytogenetics analysis of peripheral blood lymphocytes was done prospectively on 27 of 28 patients with features of DiGeorge anomaly. Twenty-two patients (81%) had normal chromosome studies with no detectable deletion in chromosome 22. Five patients (18%) had demonstrable chromosome abnormalities. Three patients had monosomy 22q11, one due to a 4q;22q translocation, one due to a 20q;22q translocation, and one due to an interstitial deletion of 22q11. One patient had monosomy 10p13, and one patient had monosomy 18q21.33, although the latter had subsequent resolution of T-cell defects. These findings are consistent with the heterogeneity of DiGeorge anomaly but confirm the association with monosomy 22q11 in some cases. However, monosomy 10p13 may also lead to this phenotype. Because of these associated chromosome findings, cytogenetic analyses should be done on patients with suspected DiGeorge anomaly. This is particularly important since many of the abnormalities involving chromosome 22 are translocations that can be familial with a higher recurrence risk. Since only one subtle, interstitial deletion of chromosome 22 was observed, it is not clear whether high-resolution cytogenetic analysis is cost beneficial for all such patients.